Organigram Global Inc. (OGI.TO)
Stock analysis · TSX · Healthcare · Drug Manufacturers - Specialty & Generic
Organigram Global Inc. (OGI.TO) is a Stock listed on the TSX, operating in the Healthcare sector as a specialty and generic drug manufacturer. The company produces and sells cannabis and cannabis-derived products in Canada, offering a range of products including whole flower and infused pre-rolls. With a diverse portfolio of brands, Organigram Global Inc. is a key player in the Canadian cannabis market. To learn more about OGI.TO's performance and trends, explore the data and analysis below.
Organigram Global Inc. (OGI.TO) is a publicly traded company in the Healthcare sector. Sign in to Stocks360 for full DCF valuation, fundamentals, technicals, and AI-driven analysis.
Get full analysis → Short-Term Analysis →Earnings
Proprietary Signals
About Organigram Global Inc.
Organigram Global Inc. engages in the production and sale of cannabis and cannabis-derived products in Canada. It offers medical cannabis products, including whole flower, milled flower, pre-rolls, infused pre-rolls, vapes, beverages, gummies, and concentrates; and adult use recreational cannabis under the SHRED, Big Bag O’ Buds, Monjour, Trailblazer, SHRED'ems, Edison Cannabis Co., Boxhot, Edison JOLTS, Wola, Rizzlers, DEBUNK, Tremblant, and Laurentian brands. The company also engages in the wholesale shipping of cannabis plant cuttings and dried flowers to other licensed producers. It sells cannabis products to wholesale and retail channels in the recreational and medical cannabis regimes, as well as through online. Organigram Global Inc. was formerly known as Organigram Holdings Inc. and changed its name to Organigram Global Inc. in March 2025. The company is headquartered in Toronto, Canada.
Peers
Recent News
Related
Browse more tickers: sitemap